Cargando…

Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS

PURPOSE: To develop a simulation model for GammaMed Plus high dose rate (192)Ir brachytherapy source in TOPAS Monte Carlo software and validate it by calculating the TG‐43 dosimetry parameters and comparing them with published data. METHODS: We built a model for GammaMed Plus high dose rate brachyth...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jianan, Xie, Yaoqin, Ding, Zhen, Li, Feipeng, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200518/
https://www.ncbi.nlm.nih.gov/pubmed/33955134
http://dx.doi.org/10.1002/acm2.13252
_version_ 1783707622185107456
author Wu, Jianan
Xie, Yaoqin
Ding, Zhen
Li, Feipeng
Wang, Luhua
author_facet Wu, Jianan
Xie, Yaoqin
Ding, Zhen
Li, Feipeng
Wang, Luhua
author_sort Wu, Jianan
collection PubMed
description PURPOSE: To develop a simulation model for GammaMed Plus high dose rate (192)Ir brachytherapy source in TOPAS Monte Carlo software and validate it by calculating the TG‐43 dosimetry parameters and comparing them with published data. METHODS: We built a model for GammaMed Plus high dose rate brachytherapy source in TOPAS. The TG‐43 dosimetry parameters including air‐kerma strength S (K), dose‐rate constant Λ, radial dose function g (L)(r), and 2D anisotropy function F(r,θ) were calculated using Monte Carlo simulation with Geant4 physics models and NNDC (192)Ir spectrum. Calculations using an old (192)Ir spectrum were also carried out to evaluate the impact of incident spectrum and cross sections. The results were compared with published data. RESULTS: For calculations using the NNDC spectrum, the air‐kerma strength per unit source activity S (K)/A and Λ were 1.0139 × 10(‐7) U/Bq and 1.1101 cGy.h(−1).U(−1), which were 3.56% higher and 0.62% lower than the reference values, respectively. The g (L)(r) agreed with reference values within 1% for radial distances from 2 mm to 20 cm. For radial distances of 1, 3, 5, and 10 cm, the agreements between F(r,θ) from this work and the reference data were within 1.5% for 15° < θ < 165°, and within 4% for all θ values. The discrepancies were attributed to the updated source spectrum and cross sections. They caused deviations of the S (K)/A of 2.90% and 0.64%, respectively. As for g (L)(r), they caused average deviations of −0.22% and 0.48%, respectively. Their impact on F(r,θ) was not quantified for the relatively high statistical uncertainties, but basically they did not result in significant discrepancies. CONCLUSION: A model for GammaMed Plus high dose rate (192)Ir brachytherapy source was developed in TOPAS and validated following TG‐43 protocols, which can be used for future studies. The impact of updated incident spectrum and cross sections on the dosimetry parameters was quantified.
format Online
Article
Text
id pubmed-8200518
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82005182021-06-15 Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS Wu, Jianan Xie, Yaoqin Ding, Zhen Li, Feipeng Wang, Luhua J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To develop a simulation model for GammaMed Plus high dose rate (192)Ir brachytherapy source in TOPAS Monte Carlo software and validate it by calculating the TG‐43 dosimetry parameters and comparing them with published data. METHODS: We built a model for GammaMed Plus high dose rate brachytherapy source in TOPAS. The TG‐43 dosimetry parameters including air‐kerma strength S (K), dose‐rate constant Λ, radial dose function g (L)(r), and 2D anisotropy function F(r,θ) were calculated using Monte Carlo simulation with Geant4 physics models and NNDC (192)Ir spectrum. Calculations using an old (192)Ir spectrum were also carried out to evaluate the impact of incident spectrum and cross sections. The results were compared with published data. RESULTS: For calculations using the NNDC spectrum, the air‐kerma strength per unit source activity S (K)/A and Λ were 1.0139 × 10(‐7) U/Bq and 1.1101 cGy.h(−1).U(−1), which were 3.56% higher and 0.62% lower than the reference values, respectively. The g (L)(r) agreed with reference values within 1% for radial distances from 2 mm to 20 cm. For radial distances of 1, 3, 5, and 10 cm, the agreements between F(r,θ) from this work and the reference data were within 1.5% for 15° < θ < 165°, and within 4% for all θ values. The discrepancies were attributed to the updated source spectrum and cross sections. They caused deviations of the S (K)/A of 2.90% and 0.64%, respectively. As for g (L)(r), they caused average deviations of −0.22% and 0.48%, respectively. Their impact on F(r,θ) was not quantified for the relatively high statistical uncertainties, but basically they did not result in significant discrepancies. CONCLUSION: A model for GammaMed Plus high dose rate (192)Ir brachytherapy source was developed in TOPAS and validated following TG‐43 protocols, which can be used for future studies. The impact of updated incident spectrum and cross sections on the dosimetry parameters was quantified. John Wiley and Sons Inc. 2021-05-05 /pmc/articles/PMC8200518/ /pubmed/33955134 http://dx.doi.org/10.1002/acm2.13252 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Wu, Jianan
Xie, Yaoqin
Ding, Zhen
Li, Feipeng
Wang, Luhua
Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS
title Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS
title_full Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS
title_fullStr Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS
title_full_unstemmed Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS
title_short Monte Carlo study of TG‐43 dosimetry parameters of GammaMed Plus high dose rate (192)Ir brachytherapy source using TOPAS
title_sort monte carlo study of tg‐43 dosimetry parameters of gammamed plus high dose rate (192)ir brachytherapy source using topas
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200518/
https://www.ncbi.nlm.nih.gov/pubmed/33955134
http://dx.doi.org/10.1002/acm2.13252
work_keys_str_mv AT wujianan montecarlostudyoftg43dosimetryparametersofgammamedplushighdoserate192irbrachytherapysourceusingtopas
AT xieyaoqin montecarlostudyoftg43dosimetryparametersofgammamedplushighdoserate192irbrachytherapysourceusingtopas
AT dingzhen montecarlostudyoftg43dosimetryparametersofgammamedplushighdoserate192irbrachytherapysourceusingtopas
AT lifeipeng montecarlostudyoftg43dosimetryparametersofgammamedplushighdoserate192irbrachytherapysourceusingtopas
AT wangluhua montecarlostudyoftg43dosimetryparametersofgammamedplushighdoserate192irbrachytherapysourceusingtopas